CoStar Group to buy Matterport in deal valued at $1.6 bln-March 2024-www.financetom.com

CoStar Group to buy Matterport in deal valued at $1.6 bln

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

CoStar Group to buy Matterport in deal valued at $1.6 bln

Apr 22, 2024 6:29 AM

April 22 (Reuters) - CoStar Group ( CSGP ) said on

Monday it would buy 3D virtual tour creator Matterport ( MTTR )

in a cash-and-stock deal valued at $1.6 billion.

Previous page： Enbridge Q3 profit misses expectations, reaffirms 2025 guidance Next page： AMC Networks Q3 revenue beats expectations as price hikes drive streaming business

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Enbridge Q3 profit misses expectations, reaffirms 2025 guidance

Nov 7, 2025

Overview * Enbridge ( ENB ) Q3 adjusted EPS misses analyst expectations, reflecting higher financing costs * Company reaffirms 2025 financial guidance and multi-year financial outlook * Enbridge ( ENB ) announces C$3 bln in sanctioned projects, including Southern Illinois Connector Outlook * Enbridge ( ENB ) reaffirms 2025 adjusted EBITDA guidance of C$19.4 bln to C$20.0 bln * Company...

AMC Networks Q3 revenue beats expectations as price hikes drive streaming business

Nov 7, 2025

Overview * AMC Networks ( AMCX ) Q3 revenue declines 6% yr/yr but beats analyst expectations * Adjusted EPS for Q3 misses analyst estimates * Adjusted operating income for Q3 beats analyst expectations * Company highlights growth in streaming revenue and strategic partnerships Outlook * AMC Networks ( AMCX ) expects full-year free cash flow of $250 mln * Streaming...

Oilwell construction services provider McCoy Global Q3 revenue down 6% on deferred shipments

Nov 7, 2025

Overview * McCoy Q3 revenue fell 6% yr/yr due to deferred shipments * Net earnings for Q3 rose 7% yr/yr despite revenue decline * Adjusted EBITDA for Q3 decreased 24% yr/yr due to shipment deferrals Outlook * McCoy expects smartProduct demand to grow in MENA region despite market headwinds * Company anticipates TRS contract awards in Eastern Hemisphere in Q1...

Prime Medicine Q3 net loss narrows

Nov 7, 2025

Overview * Prime Medicine ( PRME ) Q3 net loss narrows to $50.6 mln from $52.5 mln last year * Operating expenses rise due to increased R&D costs, offset by lower G&A expenses * Company advances liver-targeted programs, clinical data expected in 2027 Outlook * Prime Medicine expects to file IND/CTA for WD in H1 2027 * Initial clinical data...